NASDAQ:PRPH - ProPhase Labs Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$3.03 +0.05 (+1.68 %)
(As of 11/20/2018 04:00 PM ET)
Previous Close$2.98
Today's Range$3.00 - $3.03
52-Week Range$2.03 - $6.64
Volume7,200 shs
Average Volume17,875 shs
Market Capitalization$34.65 million
P/E RatioN/A
Dividend YieldN/A
Beta0.09
ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over-the-counter(OTC) consumer healthcare products, dietary supplements, and other remedies in the United States. The company offers TK Supplements product line include Legendz XL for sexual health; Triple Edge XL, an energy booster and testosterone support; and Super ProstaFlow+ for prostate and urinary health. In addition, the company provides contract manufacturing services of OTC healthcare and dietary supplements products. It markets its products through national chain, regional, specialty, and local retail stores. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Doylestown, Pennsylvania.

Receive PRPH News and Ratings via Email

Sign-up to receive the latest news and ratings for PRPH and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:PRPH
Previous Symbol
CUSIPN/A
Phone215-345-0919

Debt

Debt-to-Equity RatioN/A
Current Ratio20.79
Quick Ratio17.68

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$9.87 million
Price / Sales3.55
Cash Flow$1.2367 per share
Price / Cash2.45
Book Value$2.56 per share
Price / Book1.18

Profitability

EPS (Most Recent Fiscal Year)N/A
Net Income$40.58 million
Net Margins-11.41%
Return on Equity-4.87%
Return on Assets-4.59%

Miscellaneous

Employees46
Outstanding Shares11,550,000
Market Cap$34.65 million
OptionableNot Optionable

ProPhase Labs (NASDAQ:PRPH) Frequently Asked Questions

What is ProPhase Labs' stock symbol?

ProPhase Labs trades on the NASDAQ under the ticker symbol "PRPH."

How often does ProPhase Labs pay dividends? What is the dividend yield for ProPhase Labs?

ProPhase Labs declared a special dividend on Wednesday, May 9th. Investors of record on Monday, May 21st will be given a dividend of $1.00 per share on Tuesday, June 5th. The ex-dividend date is Friday, May 18th. View ProPhase Labs' Dividend History.

How will ProPhase Labs' stock buyback program work?

ProPhase Labs declared that its Board of Directors has authorized a stock buyback program on Saturday, November 11th 2017, which permits the company to repurchase 1,700,000 shares, according to EventVestor. This repurchase authorization permits the company to buy shares of its stock through a tender offer. Shares repurchase programs are often an indication that the company's management believes its shares are undervalued.

How were ProPhase Labs' earnings last quarter?

ProPhase Labs Inc (NASDAQ:PRPH) posted its earnings results on Wednesday, November, 14th. The company reported ($0.08) EPS for the quarter. The business earned $2.44 million during the quarter. ProPhase Labs had a negative return on equity of 4.87% and a negative net margin of 11.41%. View ProPhase Labs' Earnings History.

When is ProPhase Labs' next earnings date?

ProPhase Labs is scheduled to release their next quarterly earnings announcement on Wednesday, March 20th 2019. View Earnings Estimates for ProPhase Labs.

Has ProPhase Labs been receiving favorable news coverage?

Media headlines about PRPH stock have been trending very positive on Tuesday, InfoTrie Sentiment reports. The research group identifies positive and negative media coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. ProPhase Labs earned a news impact score of 3.1 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 8.0 out of 10, indicating that recent media coverage is very likely to have an impact on the company's share price in the next several days.

Who are some of ProPhase Labs' key competitors?

Who are ProPhase Labs' key executives?

ProPhase Labs' management team includes the folowing people:
  • Mr. Ted William Karkus, Chairman, CEO & Director (Age 59)
  • Ms. Monica Brady, Chief Accounting Officer (Age 41)

How do I buy shares of ProPhase Labs?

Shares of PRPH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is ProPhase Labs' stock price today?

One share of PRPH stock can currently be purchased for approximately $3.03.

How big of a company is ProPhase Labs?

ProPhase Labs has a market capitalization of $34.65 million and generates $9.87 million in revenue each year. ProPhase Labs employs 46 workers across the globe.

What is ProPhase Labs' official website?

The official website for ProPhase Labs is http://www.prophaselabs.com.

How can I contact ProPhase Labs?

ProPhase Labs' mailing address is 621 NORTH SHADY RETREAT ROAD, DOYLESTOWN PA, 18901. The company can be reached via phone at 215-345-0919 or via email at [email protected]


MarketBeat Community Rating for ProPhase Labs (NASDAQ PRPH)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  70 (Vote Outperform)
Underperform Votes:  84 (Vote Underperform)
Total Votes:  154
MarketBeat's community ratings are surveys of what our community members think about ProPhase Labs and other stocks. Vote "Outperform" if you believe PRPH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PRPH will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/20/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel